# Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany – FDA Inspection, May 30, 2018

Source: https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/00b592a9-1ab3-4d40-bb44-5de67256700c
Source feed: FDA_Inspections

> FDA inspection 1055544 of Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany, May 30, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1055544
- Company Name: Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany
- Inspection Date: 2018-05-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1297650 - 2025-12-08](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/ff5fde2e-4f0e-44b5-9fd6-ece34ceb3753)
- [FDA Inspection 1197680 - 2023-02-17](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/977b66ca-6f39-4a4d-b230-c50aeda40300)
- FDA Inspection 1116333 - 2019-12-20
- FDA Inspection 1027562 - 2017-08-24
- [FDA Inspection 1008344 - 2017-03-20](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/9a730984-8411-4cbd-89ee-7407053ace5a)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)
- [FDA Associated Person](https://www.keypedia.com/people/nancy-f-scheraga/7ab7500d-901f-4953-95a7-4a2b22488f04)

Company: https://www.keypedia.com/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
